focus -WSS

focus

author：comprehensive 2025-09-29 21:26:36 - browse：7

Geoff Martha, CEO of Medtronic Courtesy Medtronic

As one of the largest and oldest medical device companies in the world, Medtronic has a foot in almost every clinical area.

The device maker with a market valuation of nearly $100 billion sells pacemakers, spinal cord stimulators, stents, monitors. Name a device, and they probably make it. The behemoth is ubiquitous in health care, but its size can make innovation sluggish. Medtronic has tried to become more streamlined in recent years — the company announced plans last year to spin off its patient monitoring and respiratory businesses, which Reuters recently reported, citing unnamed sources, may go to the Carlyle Group, a private equity firm.

Still, the device giant is immersed in many different specialties, including diabetes and high blood pressure, where the company has experienced some setbacks. Medtronic has sold old-school insulin pumps since the 1980s and therefore developed robust dosing algorithms, but has never successfully built a tubeless pump. The company plans to buy Korean patch pump maker EOFlow, but EOFlow is enmeshed in a patent battle with Insulet. A federal judge blocked EOFlow from selling its wearable patch pumps earlier this month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Feng Zhang suggests Editas didn’t move quickly enough to find product targets

WSS

Biotech investment managers search for lucrative opportunities

Texas board proposes rules on abortion law emergency exemption

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Micronoma's microbiome cancer diagnostic approach under fire

Pfizer, Moderna say biotech, pharma drug development is a sprint

Mitch McConnell episode has important public health takeaway

knowledge

focus

leisure time

ChatGPT in medicine: STAT answers readers' burning questions

Scientists inch closer to single

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Illumina, CRISPR, Regeneron

Walensky prepares to leave CDC — and Congress — behind

Physician groups backed by private equity giant lobby on mergers

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Asbestos ban is immediate, but health effects will linger for decades

In Memoriam: Notable people who died in 2023

6 surprising facts about sugar

Wikipedia

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Biotech investment managers search for lucrative opportunities

6 surprising facts about sugar

Pence says 'crackpot lawyers' told Trump what he wanted to hear

5 important ways Henrietta Lacks changed medical science

leisure time

hotspot

entertainment

explore